Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients
Crossref DOI link: https://doi.org/10.1007/s13318-017-0442-x
Published Online: 2017-10-10
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Morotti, Matteo
Dass, Prashanth Hari
Harris, Adrian L.
Lord, Simon
Funding for this research was provided by:
Breast Cancer Research Foundation
Cancer Research UK
Fondazione Umberto Veronesi
License valid from 2017-10-10